Roth Capital Partners sells units of a common share and 0.75 warrants
By Devika Patel
Knoxville, Tenn., June 24 – Aethlon Medical, Inc. negotiated a $6 million private placement of units on June 23, according to an 8-K filed Wednesday with the Securities and Exchange Commission. Roth Capital Partners is the agent.
The company will sell 952,381 units of one common share and 0.75 warrants at $6.30 per unit.
Each whole warrant is exercisable at $6.30 for five years. The strike price reflects a 7.76% discount to the June 22 closing share price of $6.83.
Settlement is expected June 26.
Proceeds will be used to advance the Aethlon Hemopurifier and for general corporate purposes.
Aethlon, based in San Diego, develops therapeutic medical devices to treat viral infections.
| Issuer: | Aethlon Medical, Inc.
|
| Issue: | Units of one common share and 0.75 warrants
|
| Amount: | $6 million
|
| Shares: | 952,381
|
| Price: | $6.30
|
| Warrants: | 0.75 warrants per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $6.30
|
| Agent: | Roth Capital Partners
|
| Pricing date: | June 23
|
| Settlement date: | June 26
|
| Stock symbol: | OTCBB: AEMD
|
| Stock price: | $6.83 at close June 22
|
| Market capitalization: | $43.94 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
